Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monopar Therapeutics

42.96
+0.25000.59%
Post-market: 43.991.03+2.40%16:42 EDT
Volume:17.10K
Turnover:740.83K
Market Cap:262.60M
PE:-10.45
High:44.45
Open:43.14
Low:42.19
Close:42.71
Loading ...

Monopar Therapeutics files to sell 882,761 shares of common stock for holders

TIPRANKS
·
16 Jan

Piper Sandler Initiates Monopar Therapeutics at Overweight With $72 Price Target

MT Newswires Live
·
10 Jan

Monopar Therapeutics initiated with an Overweight at Piper Sandler

TIPRANKS
·
10 Jan

Monopar Therapeutics: Strategic Advancements and Promising Potential Drive Buy Rating

TIPRANKS
·
10 Jan

Monopar Therapeutics Inc : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $72

THOMSON REUTERS
·
10 Jan

MNPR Stock Skyrockets 384% in 3 Months After Deal With AZN

Zacks
·
02 Jan

These 2 Monster Growth Stocks Skyrocketed Over 1,000% This Year — Here’s What Analysts Expect in 2025

TipRanks
·
31 Dec 2024

What Awaits These 4 Biotech Stocks That More Than Doubled in 2024

Zacks
·
26 Dec 2024

Monopar Therapeutics Prices $40 Million Offering, Private Placement

MT Newswires Live
·
20 Dec 2024

Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants

THOMSON REUTERS
·
20 Dec 2024

Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants

GlobeNewswire
·
20 Dec 2024

Monopar Therapeutics Shares Jump After First Patient Dosed in Cancer Therapy

MT Newswires Live
·
07 Dec 2024

Monopar Therapeutics Achieves Milestone in Cancer Treatment

TIPRANKS
·
06 Dec 2024

BRIEF-Monopar Announces First Patient Dosed With Its Novel Therapeutic Radiopharmaceutical Mnpr-101-Lu

Reuters
·
06 Dec 2024

Monopar Therapeutics doses first patient with MNPR-101-Lu

TIPRANKS
·
06 Dec 2024

Monopar Announces First Patient Dosed With Its Novel Therapeutic Radiopharmaceutical Mnpr-101-Lu

THOMSON REUTERS
·
06 Dec 2024

BUZZ-JonesTrading raises PT on Monopar Therapeutics after AstraZeneca agreement

Reuters
·
20 Nov 2024

U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart

Reuters
·
20 Nov 2024

Monopar Therapeutics price target raised to $37 from $9 at JonesResearch

TIPRANKS
·
20 Nov 2024

Monopar Therapeutics Gains Buy Rating Following Strategic Agreement and Promising Phase III Results for Wilson’s Disease Treatment

TIPRANKS
·
20 Nov 2024